Gilead Sciences begins phase III trial of remdesivir for the treatment of COVID-19 in Japan April 16, 2020
Vir reports interim data from ongoing phase II study of VIR-2218 for chronic HBV infection April 16, 2020
Roivant initiates pivotal trial of gimsilumab for prevention and treatment of COVID-19-related ARDS April 16, 2020
RSS